India to Afghanistan: Erythromycin Export Trade Route

The India to Afghanistan Erythromycin corridor is one of India's established pharmaceutical export routes, with 27 shipments documented worth a combined $22.9M USD. The route is dominated by MEDOPHARM, which alone accounts for roughly 98% of all export value, reflecting the consolidated nature of India's erythromycin manufacturing sector.

Across 13 active suppliers, the average shipment value stands at $849.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 13.3%, placing it at rank #10 among India's top erythromycin export destinations globally.

On the import side, key buyers of Indian erythromycin in Afghanistan include UNICEF KABUL, UNICEF KABUL , ERRA and 12 others. UNICEF KABUL is the single largest importer with 4 shipments valued at $22.5M USD.

India's erythromycin exports to Afghanistan are driven primarily by a handful of large-scale manufacturers. MEDOPHARM with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 13 active exporters signals a competitive but concentrated market — buyers in Afghanistan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDOPHARM, MEDOPHARM , S KANT HEALTHCARE LIMITED — together account for 99% of total trade value on this route. The average shipment value of $849.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as erythromycin stearate tablets bp 250mg and harmless medicines-erythromycin ethyl succinate oral suspension bp 125mg/5ml unit:100 ml, suggesting that buyers in Afghanistan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, UNICEF KABUL is the largest importer with 4 shipments worth $22.5M USD — representing 98% of all erythromycin imports from India on this route. A total of 15 buyers are active on this corridor.